Compile Data Set for Download or QSAR

Found 1 hit Enz. Inhib. hit(s) with Target = 'Malignant T-cell-amplified sequence 1' and Ligand = 'BDBM345331'   

Target/Host (Institution)	Ligand	Target/Host Links	Ligand Links	Trg + Lig Links	Ki nM	ΔG° kJ/mole	IC50 nM	Kd nM	EC50/IC50 nM	koff s-1	kon M-1s-1	pH	Temp °C
Malignant T-cell-amplified sequence 1 (Homo sapiens (human))	BDBM345331 (US10202350, Example 77 | US10214492, Example 77 | ...) Show SMILES CC(C)(OCc1cc(Cc2ccccc2)n(Cc2ccccc2Cl)n1)C(O)=O Show InChI InChI=1S/C22H23ClN2O3/c1-22(2,21(26)27)28-15-18-13-19(12-16-8-4-3-5-9-16)25(24-18)14-17-10-6-7-11-20(17)23/h3-11,13H,12,14-15H2,1-2H3,(H,26,27)	PDB UniProtKB/SwissProt GoogleScholar AffyNet	PC cid PC sid UniChem	US Patent	n/a	n/a	9.00E+3	n/a	n/a	n/a	n/a	n/a	n/a
Vettore, LLC US Patent					Assay Description MCT1 activity may be measured using BT-20 breast cancer cells that express high native levels of MCT1, but do not express MCT4 and are known to those...				US Patent US10202350 (2019) BindingDB Entry DOI: 10.7270/Q20K2BPB
					More data for this Ligand-Target Pair